Innate Pharma
Clinical-stage biotechnology company dedicated to improving cancer treatment and clinical outcomes for patients through first-in-class therapeutic antibodies that harness the innate immune system.
Launch date
Employees
Market cap
€172m
Enterprise valuation
€115m (Public information from Sep 2024)
Share price
$2.25 IPHA
Company register number 424365336
Marseille Provence-Alpes-Côte d'Azur (HQ)
Authorizing premium user...